Otani N, Tomita K, Takata T, Kuwabara M, Kojima S, Miyazaki S, Ohta T, Hisatome I

Differential associations of transient hyperuricemia and transient hypouricemia with annual changes in estimated glomerular filtration rate in healthy participants: an observational study

BMC Nephrol.

2026.Online ahead of print.

Takano E, Terawaki H, Tajirika S, Kawamoto M, Horita R, Fukao T, Ito T, Kazama JJ, Yamamoto M

Serum uric acid level in Japanese university enrollees

Fukushima J Med Sci.

2026.Online ahead of print

Terawaki H, Tokita T, Kawagoe K, Ito T

Intradermal Tophi with Skin Findings Similar to Psoriasis

Intern Med.

2026.Online ahead of print

Sugiyama T, Otani N, Noma H, Takahashi H, Yasu T, Maejima Y

Late-systolic to early-diastolic hemodynamic force analysis in ischemic heart disease using vector flow mapping and invasive pressure measurement.

Heart Vessels

2026.Online ahead of print.

Yamamoto S, Inoue K, Yasujima T, Takei H, Yamashiro T, Asai K, Matake I, Uchiyama S, Ohta K, Kishimoto H, Higuchi K, Anayama H, Asao Y, Hirabayashi H

SLC52A1 is a neofunctionalized primate urate transporter enabling intestinal urate secretion

J Biol Chem.

2026.in press

Miyata H, Morimoto K, Hosoya T, Toyoda Y, Hosoyamada M, Takada T

Renal Nicotinate Handling by Urate Transporter 1: Hidden Benefits of Urate Transporter 1-Targetting Uricosuric Agents

Kidney360

2026; 7(1): 187-189

Takata T, Isomoto H

Back to the Physiology: Renal Tubular Handling of Uric Acid and Emerging Strategies for Managing Hyperuricemia

Intern Med.

2026; 65(4): 520-525

White SL, Brasher MS, Pattee J, Zhou W, Chapman S, Jee YH, Bell CC, Jamil TL, Barrio M, Arehart CH, Evans LM, Hirbo J, Cox NJ, Straub P, Namba S, Bertucci-Richter E, Guare L, Edris A, Morris S, Mulford AJ, Zhang H, Fennessy B, Tobin MD, Chen J, Williams AT, John C, van Heel DA, Mathur R, Finer S, Moksnes MR, Brumpton BM, Åsvold BO, Peculis R, Rovite V, Konrade I, Wang Y, Crooks K, Chavan S, Fisher MJ, Rafaels N, Lin M, Shortt JA, Sanders AR, Whiteman DC, MacGregor S, Medland SE, Thorsteinsdóttir U, Stefánsson K, Karaderi T, Egan KM, Bocklage T, McCrary HC, Riedlinger G, Salhia B, Shriver C, Phan MD, Farlow JL, Edge S, Kaur V, Churchman ML, Rounbehler RJ, Brock PL, Ringel MD, Pividori M, Schweppe R, Raeburn CD, Walters RG, Chen Z, Li L, Matsuda K, Okada Y, Zöllner S, Verma A, Penn Medicine BioBank, Preuss MH, Kenny E, Hendricks AE, Fishbein L, Kraft P, Daly MJ, Neale BM, Virtual Thyroid Biopsy Consortium, Colorado Center for Personalized Medicine, Genes & Health Research Team, BioBank Japan Project, Martin AR, Cole JB, Haugen BR, Global Biobank Meta-analysis Initiative, Gignoux CR, Pozdeyev N

Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases

Nat Genet.

2026; 58:307-316

Ishikawa T, Sonehara K, Sonoda K, Hayashi K, Kato K, Nagase S, Kusano K, Aiba T, Horie M, Ohno S, Okada Y, Makita N

A Genome-Wide Association Study Reveals Desmoglein-2 Predominance in Japanese Arrhythmogenic Cardiomyopathy

J Arrhythm.

2026; 42:e70273

Nakayama A, Hayano K, Ueno M, Miyoshi Y, Nakashima H, Shimizu S, Hashimoto I, Toba M, Kikuchi R, Takehana N, Miura M, Kawamura Y, Toyoda Y, Mizuno T, Tanabe R, Hamada Y, Tamura T, Kato Y, Mitsuda Y, Nakaoka H, Yamamoto K, Tsunoda M, Shinomiya N, Matsuo H

Dysfunctional variants of ABCG2 create strong individual and population risks for progression of hyperuricemia: the potential for implementation of genome‑personalized nursing

Hum Cell

2026; 39: 22

Ohashi Y, Ichihara S, Yamamoto K, Kitamura Y, Matsubara T, Beppo R, Kinoshita F, Kato TS, Toyoda Y, Kawamura Y, Matsuo H, Ichida K, Yokota M, Nakatochi M

Proteomic Footprint of Serum Urate Concentration and Urate Transporter ABCG2 Dysfunctional Polymorphism: A Cross-sectional Study

RMD Open

2026; 12: e006414

Morishita K, Ishii S, Maki H, Hatano M, Minatsuki S, Hirose K, Kitamura S, Kaneko S, Ando S, Kurihara T, Isotani Y, Bujo C, Tsuji M, Yagi H, Soma K, Ishida J, Amiya E, Ando M, Ono M, Takeda N

Utility of Acute Vasodilator Challenge with Inhaled Nitric Oxide to Predict Pulmonary Hemodynamic Reversibility in Patients with Pulmonary Hypertension due to Left Heart Disease Referred for Heart Transplantation.

Int Heart J.

2026;67(2):150-155

Minatsuki S, Hatano M, Ishii S, Hirose K, Matsuoka R, Kiriyama H, Saito A, Yagi H, Ishida J, Komuro I, Takeda N

Prospective safety assessment of the acute vasoreactivity test using an inhaled nitric oxide delivery system in pulmonary hypertension.

Int J Cardiol.

2026;444:134009

Yagi H, Akazawa H, Liu Q, Ito SM, Umei M, Kadowaki H, Matsuoka R, Shindo A, Okamura S, Ueda T, Saga-Kamo A, Ueda K, Takeda N, Takada T, Komuro I

Inverse Agonist Activity of Angiotensin II Receptor Blocker Is Crucial for Prevention of Progressive Aortic Dilatation in Marfan Syndrome.

Arterioscler Thromb Vasc Biol.

2026;46(1):132-144

Kawashima Y, Takeda N, Omori A, Nogimori Y, Shiraga K, Masuda H, Yagi H, Taniguchi Y, Yamauchi H, Ono M, Inuzuka R

Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome.

J Am Coll Cardiol.

2026;

Ueda H, Kubota T, Goto R, Suzuki A, Ojima T, Ogawa K, Sonehara K, Namba S, Naito T, Wang Q, Konno S, Samukawa M, Kawaguchi N, Kimura T, Sugimoto T, Murai H, Yamawaki T, Kaida K, Tokuyasu D, Yasuda M, Akamine H, Onishi Y, Ogawa Y, Shirai Y, Edahiro R, Yamamoto K, Nagata H, Ose N, Takayama J, Suzuki K, Higashiue S, Kobayashi S, Yamaguchi H, Okazaki Y, Matsumoto N, Motomura K, Koga H, Japan Myasthenia Gravis Registry, BioBank Japan Project, Tohoku Medical Megabank Project Study Group, Matsuda K, Tamiya G, Yamamoto M, Yamauchi T, Kadowaki T, Yamamoto K, Ohno A, Okuno T, Morii E, Mochizuki H, Nagane Y, Minami N, Uzawa A, Masuda M, Suzuki S, Shimomura I, Shintani Y, Utsugisawa K, Takahashi MP, Okada Y

Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma

Nat Commun.

2026;

Hirano Y, Tomofuji Y, Edahiro R, Kishikawa T, Miyawaki S, Okada Y

Association between autoimmune diseases and the gut microbiome

Int Immunol.

2026;

Hirano Y, Miyawaki S, Sonehara K, Namba S, Inoue H, Shirai Y, Imai H, Hongo H, Shimizu M, Ono H, Mizoro Y, Matsuda K, Ogawa S, Torazawa S, Sakai Y, Sato D, Tsuchiya T, Hirata S, Koizumi S, Dofuku S, Shinya Y, Kiyofuji S, Komura D, Teraoka A, Nakatomi H, Ishikawa S, Okada Y, Saito N, BioBank Japan Project

Integrative GWAS and snRNA-seq Reveal a Mesenchymal-Like Endothelial Signature in Moyamoya Disease

Stroke

2026;

Siraj L, Castro RI, Dewey HB, Kales S, Butts JC, Nguyen TTL, Kanai M, Berenzy D, Mouri K, Wang QS, Fiziev PP, Tsuo K, McCaw ZR, Gosai SJ, Aguet F, Cui R, Kassam I, McRae J, Vockley CM, Lareau CA, Abramov S, Boystov A, Vierstra J, Okada Y, Gusev A, Jones TR, Lander ES, Sabeti PC, Finucane HK, Reilly SK, Ulirsch JC, Tewhey R

Functional dissection of complex trait variants at single-nucleotide resolution

Nature

2026;

Sato G, Yamamoto Y, Sonehara K, Saiki R, Ojima T, Kanai M, Liu A, Edahiro R, Shirai Y, Namba S, Namkoong H, Hasaegawa T, Koyanagi YN, Kasugai Y, Yamaji T, Nakano S, Genovese G, Sipilä TP, Ghazal A, Tanaka H, Azekawa S, Uwamino Y, Yamamoto K, Suzuki K, Hata T, Uemura M, Takeda Y, Kanai A, Higashiue S, Kobayashi S, Afuso H, Matsuura K, Mitsumoto Y, Fujita Y, FinnGen, Japan COVID-19 Task Force, Biobank Japan Project, Oda Y, Suzuki Y, Morisaki T, Ishii M, Kitagawa Y, Koike R, Kimura A, Imoto S, Miyano S, Kanai T, Takayama J, Iwasaki M, Sawada N, Fukunaga K, Matsuo K, Kumanogoh A, Doki Y, Eguchi H, Nakagome S, Tamiya G, Ganna A, Palotie A, Daly MJ, Wilson JF, Yamamoto M, Matsuda K, Ogawa S, Yamauchi T, Kadowaki T, Okada Y

Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes

Nat Med.

2026;

Schmidt A, Alawathurage TM, David FS, Ogawa Y, Frach L, Richter S, Schaefer M, Mathey CM, Henne SK, Japan COVID-19 Task Force, Forstner AJ, Dilthey AT, Pröbstel AK, Boztug K, Nöthen MM, Namkoong H, Okada Y, Beins EC, Ludwig KU

Host control of persistent Epstein-Barr virus infection

Nature

2026;

Ishigami D, Namba S, Miyawaki S, Mitsui J, Imai H, Shimizu M, Hongo H, Dofuku S, Torazawa S, Teranishi Y, Ohara K, Sakai Y, Shimada D, Ono H, Nakatomi H, Morishita S, Tsuji S, Okada Y, Saito N

Delineating the Genetic Basis of RNF213-related vasculopathies: The association of PKHD1 variants with bilateral cerebral vasculopathy

Eur J Hum Genet.

2026;

Namba S, Sonehara K, Koyanagi YN, Kikuchi T, Ojima T, Edahiro R, Sato G, Yamaji T, Tomofuji Y, Ueda H, Yamamoto K, Ogawa Y, Suzuki K, Kanai A, Higashiue S, Kobayashi S, Yamaguchi H, Nagata Y, Okazaki Y, Matsumoto N, Motomura K, Koga H, Hishida A, Ikezaki H, Hara M, Nagayoshi M, Oze I, Nakano S, BioBank Japan Project, Oda Y, Suzuki Y, Iwasaki M, Sawada N, Matsuo K, Morisaki T, Yamauchi T, Kadowaki T, Matsuda K, Okada Y

A cross-population compendium of gene-environment interactions

Nature

2026;

Motomura T, Higashi M, Hattori A, Akiyama R, Kai H

Efficacy and Safety of Dotinurad in Patients with Advanced Chronic Kidney Disease

Intern Med.

2026 Mar 15; 65(6): 788-794

Nagata K, Taniguchi Y, Nakajima K, Nakarai H, Takeda N, Yagi H, Inuzuka R, Nakamoto H, Kato S, Tanaka S, Oshima Y

Bone mineral density in pediatric Marfan syndrome patients with scoliosis: a retrospective case-control study using Hounsfield units.

Eur Spine J.

2026 Mar 27

Notsu T, Kurata Y, Tsuneto M, Kuwabara M, Otani N, Nanba D, Hisatome I

Soluble uric acid enhances gouty inflammation via activating gene expression related to innate immune responses, M1 macrophage polarization and urate crystal phagocytosis in mouse macrophage-like cells: novel insights into its mechanisms from RNA sequencing.

Hypertens Res.

2026 Mar 13. Online ahead of print.

Chen J, Zhao H, Xi Y, Fu S, Xie D, Yu L, Wang Q, Chen B, Zhang Q, Zhang M, Ye X, Wu M, Que W, Chen S, Liu Y, Yamamoto T, Koyama H, Zhao H*, Cheng J*

Activation of mitophagy antagonizes high uric acid-induced hepatic lipid accumulation.

J Biol Chem.

2026 Feb;302(2):111054.

Hosaka I, Tanaka M, Sato T, Akiyama Y, Nishizawa K, Matsumori R, Aida H, Kawaharata W, Nakata K, Abe K, Suzuki T, Kouzu H, Yama N, Hanawa N, Furuhashi M

Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering Techniques

Hepatol Res

2026 Jan 26. doi: 10.1111/hepr.70127. Epub ahead of print.

Takata T, Mae Y, Hoi S, Hisatome I, Isomoto H

Redefining hyperuricemia in chronic kidney disease: a focus on tubulo-glomerular urate handling

Hypertens Res.

2025;48(10):2766-2767

Yagi H, Akazawa H, Liu Q, Yamamoto K, Nawata K, Saga-Kamo A, Umei M, Kadowaki H, Matsuoka R, Shindo A, Okamura S, Toko H, Takeda N, Ando M, Yamauchi H, Takeda N, Fini MA, Ono M, Komuro I

XOR-Derived ROS in Tie2-Lineage Cells Including Endothelial Cells Promotes Aortic Aneurysm Progression in Marfan Syndrome

Arterioscler Thromb Vasc Biol.

2025;45(3):e63-e77

Mashitani Y, Ogawa K, Funaki R, Tanaka Y, Oh T, Tanaka TD, Nagoshi T, Minai K, Kawai M, Yoshimura M

Association between mixed venous oxygen saturation and serum uric acid levels in patients with heart failure.

PLoS One

2025;20:e0306353

Sakaguchi T, Funakoshi S, Kawano K, Ueno T, Maki K, Morinaga A, Iwanaga K, Inoue Y, Shinohara Y, Katsuki S, Takahashi K, Ishida S, Fujii T, Abe M, Kawazoe M, Maeda T, Yoshimura C, Tada K, Ito K, Mukobara S, Masutani K, Inoue T, Nagamitsu S, Arima H

Non-fasting and fasting serum triglyceride concentrations and new-onset hyperuricemia in the general Japanese population: ISSA-CKD study

Sci Rep.

2025;15(1):5764

Fujii W, Yamazaki O, Hirohama D, Kaseda K, Kuribayashi-Okuma E, Tsuji M, Hosoyamada M, Kochi Y, Shibata S

Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12

J Clin Invest.

2025;135(10):e186633.

Otani N, Hamada T, Kuwabara M, Miyazaki S, Sato Y, Nakayama T, Ninomiya H, Konta T, Hisatome I

Changes in Practitioners' Attitudes toward the Recommendations for Clinical Questions of the Japanese Guideline for Management of Hyperuricemia and Gout, Third Edition between 2018 and 2020 in the Questionnaire's Surveys: Involving Their Attitude toward the New Questionnaires in 2020.

JMA J

2025; 8: 470-478.

Matake I, Yasujima T*, Matsuo H, Nakayama A, Toyoda Y, Takada T, Inoue K, Yamashiro T, Yuasa H

ENT3: A lysosomal urate transporter regulating urate disposition and macrophage inflammation

iScience

2025; 8(12):114229

Toyoda Y, Saito H, Hirata H, Ota-Kontani A, Tsuchiya Y, Takada T

Investigation of the inhibitory effects of fatty acid derivatives on URAT1 function, a renal urate re-absorber

J Nutr Sci Vitaminol (Tokyo).

2025; 71(4):331–338

Higashikuni Y, Platt C, Hastings MH, Chen WCW, Guerra JRB, Tokuyama T, Torizal FG, Liu W, Obana T, Bayer AL, Whipple H, Kuznetsov A, Yeri A, Turissini C, Kitchen RR, Shibayama K, Matsumura T, Takeda N, Uosaki H, Asnani AH, Lu TK, Rosenzweig A

Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM)

JACC CardioOncol.

2025; 7(4): 396-410

Hisatome I, Tomita K, Kato R, Ikeuchi T, Touge H, Hamada T, Goto T, Ninomiya H, Otani N, Kuwabara M, Miyazaki S, Yamasaki A

Prediction for Risk of Hypouricemia in Hospitalized Patients: A Single-center, Retrospective Cohort Study.

Intern Med.

2025; 64: 1009-1016.

Matake I, Yasujima T*, Matsuo H, Toyoda Y, Kawamura Y, Takada T, Inoue K, Yamashiro T, Yuasa H

Functional characteristics of equilibrative nucleoside transporter 2 (ENT2/SLC29A2) for the transport of urate as a newly identified substrate

Drug Metab Pharmacokinet.

2025; 62:101048

Toyoda Y, Pavelcova K, Masinova J, Hasikova L, Zavada J, Hanova P, Klein M, Vavra J, Takada T, Stiburkova B

Identification of pathogenic variants in the ABCG2 gene in patients with severe familial hyperuricemia and gout

Mol Cell Biochem.

2025; 480(7):4259–4264

Terawaki H, Yoshimura R, Ueda H, Tajirika S, Kawamoto M, Horita R, Fukao T, Ito Y, Ito T, Yamamoto M

Elevated uric acid levels as a risk factor for new-onset hypertension in newly enrolled Japanese university students

Hypertens Res.

2025; 48(2): 780-785.

Matsushita D, Toyoda Y, Lee Y, Maeda A, Matsuo H, Takada T, Nishizawa T

Structural basis of urate reabsorption by glucose transporter 9

Cell Rep.

2025; 44(4):115514

Zhang Q, Chen B, Xie D, Yu L, Chen J, Yan Y, Wang Q, Xi Y, Xu C, Hisatome I, Yamamoto T, Koyama H, Cheng J*

UA stimulates PINK1/Parkin-mediated mitophagy reducing Aβ-induced neuronal apoptosis via the Nrf2/HO-1 pathway.

Antioxid Redox Signal.

2025; 43(7-9):381-399.

Terashima M, Tamura Y, Takahashi H, Ochiai K, Ehara K, Takahashi M, Otani N, Sandor B, Tomoe T, Sugiyama T, Ueno A, Kitahara K, Kawabe A, Yasu T

Effects of cardiac rehabilitation on in vivo nailfold microcirculation in patients with cardiovascular disease.

Heart Vessels

2025; 40: 72-85.

Kaneko N, Smith GL, Loughrey CM, Matsuda R, Kusano K, Inoue Y, Otani N, Toda M, Scott K, Da Silva Costa A, Dobi S, Saxena P, Mark PB, Shinozaki M, Kambayashi R, Riddell A, Elliott EB, McCarroll CS, Kitai T, Hasunuma T, Shimamoto K, Sakai T, Nakamura M, Kikuchi M, Toyoda S, Ishikawa T, Kumagai K, Taguchi I, Sugiyama A, Kihara Y, Fujiwara T, Kumagai Y, Iwata K

Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.

J Pharmacol Exp Ther

2025; 392: 103652.

Ehara K, Tamura Y, Takahashi H, Terashima M, Takahashi M, Tsurumi T, Sugimura H, Otani N, Tomoe T, Kitahara K, Sugiyama T, Yasu T

Preconditioning Effects of Neuromuscular Electrical Stimulation in Patients with Symptomatic Peripheral Arterial Disease.

J Atheroscler Thromb

2025; 32: 1027-1037

Toyoda Y, Shigesawa R, Merriman TR, Matsuo H, Takada T

GLUT2/SLC2A2 is a bi-directional urate transporter

J Biol Chem.

2025; 301(5):108485

Tanaka R, Miyazaki E, Mori T, Nakamori K, Motoki K, Banno Y

Functional Evaluation of Glucose Intolerance in NBRP-o06 Silkworm Strains: Consideration as an Alternative Experimental Animal

Altern Anim Test Exp.

2025; 30 (2), 87-98

Takata T, Mae Y, Hoi S, Iyama T, Isomoto H

Hyperuricemia in Chronic Kidney Disease: Emerging Pathophysiology and a Novel Therapeutic Strategy

Int J Mol Sci.

2025; 26(18): 9000

Takata T, Taniguchi S, Mae Y, Kageyama K, Fujino Y, Iyama T, Hikita K, Sugihara T, Isomoto H

Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia

Sci Rep.

2025; 15(1): 8990

Isotani Y, Amiya E, Hatano M, Ishida J, Tsuji M, Bujo C, Minatsuki S, Kurihara T, Ishii S, Yagi H, Saito A, Kiriyama H, Numata G, Kaneko S, Ando S, Morishita K, Takeda N, Komuro I

Right Ventricular Systolic and Diastolic Parameters on the Basis of Pressure-Volume Loop Theory in Patients With Heart Failure.

Can J Cardiol.

2025;41(12):2440-2450

Ueda T, Yagi H, Akiyama N, Akiba N, Hoshina K, Akazawa H, Takeda N

Pregnant Patient With Infrarenal Abdominal Aortic Aneurysm Successfully Treated With EVAR.

JACC Case Rep.

2025;30(30):105287

Kurihara T, Amiya E, Hatano M, Ishida J, Bujo C, Isotani Y, Kaneko S, Ando S, Morishita K, Ishii S, Ueda T, Yagi H, Saito A, Soma K, Minatsuki S, Ando M, Shimada S, Ono M, Takeda N

Fibrosis 4 Index Predicts Haemocompatibility-Related Adverse Events in Patients Using Left Ventricular Assist Devices.

Eur J Cardiothorac Surg.

2025;67(9):ezaf291

Kurozumi A, Minatsuki S, Hatano M, Tsujimoto T, Gota Fujisawa G, Ishii S, Yagi H, Shimbo M, Ikemura M, Fujishiro M, Takeda N

A Case of Recurrent Pulmonary Tumor Thrombotic Microangiopathy Associated With Gastric Adenocarcinoma Following Imatinib Discontinuation.

Pulm Circ.

2025;15(3):e70143

Sowa H, Yagi H, Ueda K, Hashimoto M, Karasaki K, Liu Q, Kurozumi A, Adachi Y, Yanase T, Okamura S, Zhai B, Takeda N, Ando M, Yamauchi H, Ito N, Ono M, Akazawa H, Komuro I

Perivascular inflammation in the progression of aortic aneurysms in Marfan syndrome.

JCI Insight.

2025;e184329

Ueda T, Amiya E, Hatano M, Inoue K, Ishida J, Minatsuki S, Yagi H, Bujo C, Isotani Y, Kakuda N, Yamada T, Takeda N, Akazawa H, Kanaoka K, Onoue K, Saito Y, Hikoso S, Komuro I

Prognostic Factors Associated With Early Recovery From Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients With Fulminant Myocarditis.

J Am Heart Assoc.

2025;14(12):e039673

Yagi H, Akazawa H, Liu Q, Yamamoto K, Nawata K, Saga-Kamo A, Umei M, Kadowaki H, Matsuoka R, Shindo A, Okamura S, Toko H, Takeda N, Ando M, Yamauchi H, Takeda N, Fini MA, Ono M, Komuro I

XOR-Derived ROS in Tie2-Lineage Cells Including Endothelial Cells Promotes Aortic Aneurysm Progression in Marfan Syndrome.

Arterioscler Thromb Vasc Biol.

2025;45(3):e63-e77

Xie D, Zheng Q, Lv J, Zhang Q, Cui Z, Huang S, Yu W, Chen B, Que W, Fu S, Xi Y, Chen J, Ye X, Chen S, Zhao H, Yamamoto T, Koyama H, Wang X*, Cheng J*

Uric Acid Functions as an Endogenous Modulator of Microglial Function and Amyloid Clearance in Alzheimer's Disease.

Adv Sci (Weinh).

2025 Oct 6:e10270.

Matsushita Y, Otani N, Tomoe T, Mizuguchi S, Ono S, Kitahara K, Sugiyama T, Yasu T, Maejima Y

Unmasking Type 1 Brugada Pattern Following Pilsicainide Administration for Paroxysmal Atrial Fibrillation: A Case Report.

JMA J.

2025 Oct 15;8(4):1459-1462.

Wang Q, Xi Y, Zhao H, Xie D, Yu L, Yan Y, Chen J, Zhang Q, Liang M, Cheng J*

Ferroptosis mediates the progression of hyperuricemic nephropathy by activating RAGE signaling.

Antioxid Redox Signal.

2025 Jul;43(1-3):56-74.

Otani N, Ono S, Sugiyama T, Harasawa H, Yasu T

Successful upfront combination therapy against pulmonary arterial hypertension associated with unilateral absence of the pulmonary artery: a case report.

Eur Heart J Case Rep.

2025 Jul 10;9(7):ytaf328.

Kurajoh M, Fukumoto S, Akari S, Nakamura T, Miki Y, Nagata Y, Morioka T, Mori K, Imanishi Y, Watanabe T, Emoto M

Association of hepatic steatosis with increased plasma xanthine oxidoreductase activity: MedCity21 health examination registry

Metabol Open

2025 Jun 13:27:100374.

Tagaya M, Otani N, Sato A, Irisawa A, Maejima Y

Pancreatic Cancer Presenting With Hematemesis and Hemorrhagic Shock Following Anticoagulation With Unfractionated Heparin for Cancer-Related Venous Thromboembolism.

Cureus.

2025 May 20;17(5):e84498.

Noma H, Otani N, Toyoda S, Yasu T

Significant morphological changes in the right ventricular septal moderator band on echocardiography due to changes in right ventricular volume and pressure.

J Med Ultrason (2001).

2025 Apr;52(2):261-262.

Chihara Y, Wakabayashi I, Kataoka Y, Yamamoto T

Serum creatinine is more strongly associated with hyperuricemia than eGFR in males but not in females

Mod Rheumatol.

2025 Feb 21;35(2):378-385.

Amano H, Kobayashi S, Terawaki H

Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease

BMC Nephrol.

2024; 25(1): 97.